{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:47:14Z","timestamp":1792194434759,"version":"4.4.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11060-025-05033-w","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:58:03Z","timestamp":1744617483000},"page":"683-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers"],"prefix":"10.1007","volume":"173","author":[{"given":"Samuel","family":"Adida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchet","family":"Taori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayaan","family":"Tirmizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal O.","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Flickinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta K.","family":"Sefcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Gerszten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"5033_CR1","doi-asserted-by":"publisher","unstructured":"Jardim SR, de Souza LMP, de Souza HSP (2023) The rise of Gastrointestinal cancers as a global phenomenon: unhealthy behavior or progress? Int J Environ Res Public Health Feb 18(4). https:\/\/doi.org\/10.3390\/ijerph20043640","DOI":"10.3390\/ijerph20043640"},{"issue":"11","key":"5033_CR2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/cac2.12220","volume":"41","author":"L Lu","year":"2021","unstructured":"Lu L, Mullins CS, Schafmayer C, Zeissig S, Linnebacher M (2021) A global assessment of recent trends in Gastrointestinal cancer and lifestyle-associated risk factors. Cancer Commun (Lond) Nov 41(11):1137\u20131151. https:\/\/doi.org\/10.1002\/cac2.12220","journal-title":"Cancer Commun (Lond) Nov"},{"key":"5033_CR3","doi-asserted-by":"publisher","unstructured":"Huang Y, Huang H, Wei T et al (2024) Disparities, trends, and predictions to 2040 in Gastrointestinal cancer incidence, mortality in the united States. Am J Gastroenterol Nov 12. https:\/\/doi.org\/10.14309\/ajg.0000000000003198","DOI":"10.14309\/ajg.0000000000003198"},{"key":"5033_CR4","doi-asserted-by":"publisher","unstructured":"Murphy AG, Lynch D, Kelly RJ (Sep 2015) State of the Art management of metastatic gastroesophageal cancer. Ann Transl Med 3(16):236. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.09.19","DOI":"10.3978\/j.issn.2305-5839.2015.09.19"},{"key":"5033_CR5","doi-asserted-by":"publisher","first-page":"175883592412294","DOI":"10.1177\/17588359241229428","volume":"16","author":"T Ogata","year":"2024","unstructured":"Ogata T, Narita Y, Oze I et al (2024) Chronological improvement of survival in patients with advanced gastric cancer over 15 years. Ther Adv Med Oncol 16:17588359241229428. https:\/\/doi.org\/10.1177\/17588359241229428","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"5033_CR6","doi-asserted-by":"publisher","first-page":"e2236666","DOI":"10.1001\/jamanetworkopen.2022.36666","volume":"3","author":"N Reboux","year":"2022","unstructured":"Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM (2022) Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer. JAMA Netw Open Oct 3(10):e2236666. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.36666","journal-title":"JAMA Netw Open Oct"},{"key":"5033_CR7","doi-asserted-by":"publisher","first-page":"107327482312117","DOI":"10.1177\/10732748231211764","volume":"30","author":"V Nghiem","year":"2023","unstructured":"Nghiem V, Wood S, Ramachandran R et al (2023) Short- and Long-Term survival of metastatic biliary tract cancer in the united States from 2000 to 2018. Cancer Control Jan-Dec 30:10732748231211764. https:\/\/doi.org\/10.1177\/10732748231211764","journal-title":"Cancer Control Jan-Dec"},{"issue":"1","key":"5033_CR8","doi-asserted-by":"publisher","first-page":"15421","DOI":"10.1038\/s41598-023-42083-4","volume":"18","author":"B Doleschal","year":"2023","unstructured":"Doleschal B, Taghizadeh H, Webersinke G et al (2023) Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment. Sci Rep Sep 18(1):15421. https:\/\/doi.org\/10.1038\/s41598-023-42083-4","journal-title":"Sci Rep Sep"},{"issue":"1","key":"5033_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41698-023-00353-4","volume":"13","author":"FA Zeineddine","year":"2023","unstructured":"Zeineddine FA, Zeineddine MA, Yousef A et al (2023) Survival improvement for patients with metastatic colorectal cancer over Twenty years. NPJ Precis Oncol Feb 13(1):16. https:\/\/doi.org\/10.1038\/s41698-023-00353-4","journal-title":"NPJ Precis Oncol Feb"},{"issue":"36","key":"5033_CR10","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.3748\/wjg.v17.i36.4067","volume":"28","author":"EP Misiakos","year":"2011","unstructured":"Misiakos EP, Karidis NP, Kouraklis G (2011) Current treatment for colorectal liver metastases. World J Gastroenterol Sep 28(36):4067\u20134075. https:\/\/doi.org\/10.3748\/wjg.v17.i36.4067","journal-title":"World J Gastroenterol Sep"},{"issue":"2","key":"5033_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3978\/j.issn.2078-6891.2015.092","volume":"7","author":"R Assi","year":"2016","unstructured":"Assi R, Mukherji D, Haydar A, Saroufim M, Temraz S, Shamseddine A (2016) Metastatic colorectal cancer presenting with bone marrow metastasis: a case series and review of literature. J Gastrointest Oncol Apr 7(2):284\u2013297. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.092","journal-title":"J Gastrointest Oncol Apr"},{"key":"5033_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jbo.2018.09.009","volume":"13","author":"TD Christensen","year":"2018","unstructured":"Christensen TD, Jensen SG, Larsen FO, Nielsen DL (2018) Systematic review: incidence, risk factors, survival and treatment of bone metastases from colorectal cancer. J Bone Oncol Nov 13:97\u2013105. https:\/\/doi.org\/10.1016\/j.jbo.2018.09.009","journal-title":"J Bone Oncol Nov"},{"key":"5033_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/JHC.S417273","volume":"10","author":"M Ozer","year":"2023","unstructured":"Ozer M, Goksu SY, Lin RY et al (2023) Effects of clinical and tumor characteristics on survival in patients with hepatocellular carcinoma with bone metastasis. J Hepatocell Carcinoma 10:1129\u20131141. https:\/\/doi.org\/10.2147\/JHC.S417273","journal-title":"J Hepatocell Carcinoma"},{"issue":"42","key":"5033_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17420","volume":"17","author":"P Sutcliffe","year":"2013","unstructured":"Sutcliffe P, Connock M, Shyangdan D, Court R, Kandala NB, Clarke A (2013) A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression. Health Technol Assess Sep 17(42):1\u2013274. https:\/\/doi.org\/10.3310\/hta17420","journal-title":"Health Technol Assess Sep"},{"issue":"9","key":"5033_CR15","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.spinee.2021.04.012","volume":"21","author":"DM Sciubba","year":"2021","unstructured":"Sciubba DM, Pennington Z, Colman MW et al (2021) Spinal metastases 2021: a review of the current state of the Art and future directions. Spine J Sep 21(9):1414\u20131429. https:\/\/doi.org\/10.1016\/j.spinee.2021.04.012","journal-title":"Spine J Sep"},{"key":"5033_CR16","doi-asserted-by":"publisher","unstructured":"Gerszten PC, Mendel E, Yamada Y (2009) Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine (Phila Pa 1976). Oct 15(22 Suppl):S78\u201392. https:\/\/doi.org\/10.1097\/BRS.0b013e3181b8b6f5","DOI":"10.1097\/BRS.0b013e3181b8b6f5"},{"issue":"11","key":"5033_CR17","doi-asserted-by":"publisher","first-page":"12318","DOI":"10.18632\/oncotarget.7131","volume":"15","author":"H Soliman","year":"2016","unstructured":"Soliman H, Das S, Larson DA, Sahgal A (2016) Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases. Oncotarget Mar 15(11):12318\u201312330. https:\/\/doi.org\/10.18632\/oncotarget.7131","journal-title":"Oncotarget Mar"},{"key":"5033_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13014-014-0226-2","volume":"16","author":"M Guckenberger","year":"2014","unstructured":"Guckenberger M, Mantel F, Gerszten PC et al (2014) Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis. Radiat Oncol Oct 16:9:226. https:\/\/doi.org\/10.1186\/s13014-014-0226-2","journal-title":"Radiat Oncol Oct"},{"key":"5033_CR19","doi-asserted-by":"publisher","first-page":"109969","DOI":"10.1016\/j.radonc.2023.109969","volume":"190","author":"RS Guninski","year":"2024","unstructured":"Guninski RS, Cuccia F, Alongi F et al (2024) Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for Preparation of an ESTRO practice guideline. Radiother Oncol Jan 190:109969. https:\/\/doi.org\/10.1016\/j.radonc.2023.109969","journal-title":"Radiother Oncol Jan"},{"issue":"7","key":"5033_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal A, Myrehaug SD, Siva S et al (2021) Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial. Lancet Oncol Jul 22(7):1023\u20131033. https:\/\/doi.org\/10.1016\/S1470-2045(21)00196-0","journal-title":"Lancet Oncol Jul"},{"issue":"4","key":"5033_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3171\/2014.10.SPINE14252","volume":"22","author":"BG Bate","year":"2015","unstructured":"Bate BG, Khan NR, Kimball BY, Gabrick K, Weaver J (2015) Stereotactic radiosurgery for spinal metastases with or without separation surgery. J Neurosurg Spine Apr 22(4):409\u2013415. https:\/\/doi.org\/10.3171\/2014.10.SPINE14252","journal-title":"J Neurosurg Spine Apr"},{"issue":"6","key":"5033_CR22","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamaoncol.2023.0356","volume":"1","author":"S Ryu","year":"2023","unstructured":"Ryu S, Deshmukh S, Timmerman RD et al (2023) Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine: phase 3 results of NRG oncology\/rtog 0631 randomized clinical trial. JAMA Oncol Jun 1(6):800\u2013807. https:\/\/doi.org\/10.1001\/jamaoncol.2023.0356","journal-title":"JAMA Oncol Jun"},{"issue":"2","key":"5033_CR23","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.prro.2021.10.004","volume":"12","author":"S Faruqi","year":"2022","unstructured":"Faruqi S, Chen H, Fariselli L et al (2022) Stereotactic radiosurgery for postoperative spine malignancy: A systematic review and international stereotactic radiosurgery society practice guidelines. Pract Radiat Oncol Mar-Apr 12(2):e65\u2013e78. https:\/\/doi.org\/10.1016\/j.prro.2021.10.004","journal-title":"Pract Radiat Oncol Mar-Apr"},{"issue":"5","key":"5033_CR24","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ijrobp.2016.03.027","volume":"1","author":"KJ Redmond","year":"2016","unstructured":"Redmond KJ, Lo SS, Fisher C, Sahgal A (2016) Postoperative stereotactic body radiation therapy (SBRT) for spine metastases: A critical review to guide practice. Int J Radiat Oncol Biol Phys Aug 1(5):1414\u20131428. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.027","journal-title":"Int J Radiat Oncol Biol Phys Aug"},{"issue":"3","key":"5033_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3171\/2016.8.SPINE16121","volume":"26","author":"KJ Redmond","year":"2017","unstructured":"Redmond KJ, Lo SS, Soltys SG et al (2017) Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. J Neurosurg Spine Mar 26(3):299\u2013306. https:\/\/doi.org\/10.3171\/2016.8.SPINE16121","journal-title":"J Neurosurg Spine Mar"},{"issue":"5","key":"5033_CR26","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","volume":"1","author":"BW Cox","year":"2012","unstructured":"Cox BW, Spratt DE, Lovelock M et al (2012) International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys Aug 1(5):e597\u2013605. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.009","journal-title":"Int J Radiat Oncol Biol Phys Aug"},{"key":"5033_CR27","doi-asserted-by":"publisher","first-page":"109966","DOI":"10.1016\/j.radonc.2023.109966","volume":"190","author":"M Guckenberger","year":"2024","unstructured":"Guckenberger M, Andratschke N, Belka C et al (2024) ESTRO clinical practice guideline: stereotactic body radiotherapy for spine metastases. Radiother Oncol Jan 190:109966. https:\/\/doi.org\/10.1016\/j.radonc.2023.109966","journal-title":"Radiother Oncol Jan"},{"issue":"3","key":"5033_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11060-011-0777-0","volume":"107","author":"UK Chang","year":"2012","unstructured":"Chang UK, Cho WI, Lee DH et al (2012) Stereotactic radiosurgery for primary and metastatic sarcomas involving the spine. J Neurooncol May 107(3):551\u2013557. https:\/\/doi.org\/10.1007\/s11060-011-0777-0","journal-title":"J Neurooncol May"},{"issue":"3","key":"5033_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2017.1.SPINE161045","volume":"27","author":"AJ Bishop","year":"2017","unstructured":"Bishop AJ, Tao R, Guadagnolo BA et al (2017) Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine Sep 27(3):303\u2013311. https:\/\/doi.org\/10.3171\/2017.1.SPINE161045","journal-title":"J Neurosurg Spine Sep"},{"issue":"3","key":"5033_CR30","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2014.11.FOCUS14716","volume":"38","author":"JP Caruso","year":"2015","unstructured":"Caruso JP, Cohen-Inbar O, Bilsky MH, Gerszten PC, Sheehan JP (2015) Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma. Neurosurg Focus Mar 38(3):E6. https:\/\/doi.org\/10.3171\/2014.11.FOCUS14716","journal-title":"Neurosurg Focus Mar"},{"issue":"5\u20136","key":"5033_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000091952","volume":"83","author":"PC Gerszten","year":"2005","unstructured":"Gerszten PC, Burton SA, Quinn AE, Agarwala SS, Kirkwood JM (2005) Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg 83(5\u20136):213\u2013221. https:\/\/doi.org\/10.1159\/000091952","journal-title":"Stereotact Funct Neurosurg"},{"issue":"6","key":"5033_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.6004\/jnccn.2015.0093","volume":"13","author":"NK Taunk","year":"2015","unstructured":"Taunk NK, Spratt DE, Bilsky M, Yamada Y (2015) Spine radiosurgery in the management of renal cell carcinoma metastases. J Natl Compr Canc Netw Jun 13(6):801\u2013809 quiz 809. https:\/\/doi.org\/10.6004\/jnccn.2015.0093","journal-title":"J Natl Compr Canc Netw Jun"},{"key":"5033_CR33","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1016\/j.wneu.2017.10.011","volume":"109","author":"BW Smith","year":"2018","unstructured":"Smith BW, Joseph JR, Saadeh YS et al (2018) Radiosurgery for treatment of renal cell metastases to spine: A systematic review of the literature. World Neurosurg Jan 109:e502\u2013e509. https:\/\/doi.org\/10.1016\/j.wneu.2017.10.011","journal-title":"World Neurosurg Jan"},{"key":"5033_CR34","doi-asserted-by":"publisher","first-page":"100815","DOI":"10.1016\/j.ctro.2024.100815","volume":"48","author":"M Bilski","year":"2024","unstructured":"Bilski M, Korab K, Stapor-Fudzinska M et al (2024) HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases - A dosimetric comparison study of three radioablative techniques. Clin Transl Radiat Oncol Sep 48:100815. https:\/\/doi.org\/10.1016\/j.ctro.2024.100815","journal-title":"Clin Transl Radiat Oncol Sep"},{"key":"5033_CR35","doi-asserted-by":"publisher","first-page":"1478872","DOI":"10.3389\/fonc.2024.1478872","volume":"14","author":"M Bilski","year":"2024","unstructured":"Bilski M, Peszynska-Piorun M, Konat-Baska K et al (2024) Radiotherapy as a metastasis directed therapy for liver oligometastases - comparative analysis between CT-guided interstitial HDR brachytherapy and two SBRT modalities performed on double-layer and single layer LINACs. Front Oncol 14:1478872. https:\/\/doi.org\/10.3389\/fonc.2024.1478872","journal-title":"Front Oncol"},{"issue":"5","key":"5033_CR36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ijrobp.2015.04.004","volume":"1","author":"MS Binkley","year":"2015","unstructured":"Binkley MS, Trakul N, Jacobs LR et al (2015) Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy. Int J Radiat Oncol Biol Phys Aug 1(5):1044\u20131052. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.004","journal-title":"Int J Radiat Oncol Biol Phys Aug"},{"issue":"1","key":"5033_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3171\/2020.1.SPINE191260","volume":"1","author":"N Sandhu","year":"2020","unstructured":"Sandhu N, Benson KRK, Kumar KA et al (2020) Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of Gastrointestinal origin. J Neurosurg Spine Jul 1(1):87\u201394. https:\/\/doi.org\/10.3171\/2020.1.SPINE191260","journal-title":"J Neurosurg Spine Jul"},{"issue":"1","key":"5033_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11060-014-1463-9","volume":"119","author":"UK Chang","year":"2014","unstructured":"Chang UK, Kim MS, Han CJ, Lee DH (2014) Clinical result of stereotactic radiosurgery for spinal metastasis from hepatocellular carcinoma: comparison with conventional radiation therapy. J Neurooncol Aug 119(1):141\u2013148. https:\/\/doi.org\/10.1007\/s11060-014-1463-9","journal-title":"J Neurooncol Aug"},{"issue":"3","key":"5033_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3857\/roj.2015.33.3.217","volume":"33","author":"E Lee","year":"2015","unstructured":"Lee E, Kim TG, Park HC et al (2015) Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma. Radiat Oncol J Sep 33(3):217\u2013225. https:\/\/doi.org\/10.3857\/roj.2015.33.3.217","journal-title":"Radiat Oncol J Sep"},{"issue":"1","key":"5033_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3340\/jkns.2016.59.1.37","volume":"59","author":"S Sohn","year":"2016","unstructured":"Sohn S, Chung CK, Sohn MJ, Kim SH, Kim J, Park E (2016) Radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from hepatocellular carcinoma: A multicenter, Matched-Pair study. J Korean Neurosurg Soc Jan 59(1):37\u201343. https:\/\/doi.org\/10.3340\/jkns.2016.59.1.37","journal-title":"J Korean Neurosurg Soc Jan"},{"issue":"42","key":"5033_CR41","doi-asserted-by":"publisher","first-page":"72860","DOI":"10.18632\/oncotarget.20529","volume":"22","author":"GS Yoo","year":"2017","unstructured":"Yoo GS, Park HC, Yu JI et al (2017) Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture. Oncotarget Sep 22(42):72860\u201372871. https:\/\/doi.org\/10.18632\/oncotarget.20529","journal-title":"Oncotarget Sep"},{"issue":"2","key":"5033_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.prro.2018.11.009","volume":"9","author":"HM McGee","year":"2019","unstructured":"McGee HM, Carpenter TJ, Ozbek U et al (2019) Analysis of local control and pain control after spine stereotactic radiosurgery reveals inferior outcomes for hepatocellular carcinoma compared with other radioresistant histologies. Pract Radiat Oncol Mar 9(2):89\u201397. https:\/\/doi.org\/10.1016\/j.prro.2018.11.009","journal-title":"Pract Radiat Oncol Mar"},{"issue":"2","key":"5033_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11060-020-03522-8","volume":"148","author":"O Gjyshi","year":"2020","unstructured":"Gjyshi O, Boyce-Fappiano D, Pezzi TA et al (2020) Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol Jun 148(2):327\u2013334. https:\/\/doi.org\/10.1007\/s11060-020-03522-8","journal-title":"J Neurooncol Jun"},{"issue":"11","key":"5033_CR44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/COC.0000000000000864","volume":"1","author":"KRK Benson","year":"2021","unstructured":"Benson KRK, Sandhu N, Zhang C et al (2021) Local recurrence outcomes of colorectal cancer oligometastases treated with stereotactic ablative radiotherapy. Am J Clin Oncol Nov 1(11):559\u2013564. https:\/\/doi.org\/10.1097\/COC.0000000000000864","journal-title":"Am J Clin Oncol Nov"},{"issue":"12","key":"5033_CR45","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/jjco\/hyaa128","volume":"16","author":"K Ito","year":"2020","unstructured":"Ito K, Yamaguchi T, Ogawa H, Nakajima Y, Karasawa K (2020) Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer. Jpn J Clin Oncol Dec 16(12):1442\u20131446. https:\/\/doi.org\/10.1093\/jjco\/hyaa128","journal-title":"Jpn J Clin Oncol Dec"},{"issue":"5","key":"5033_CR46","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ijrobp.2017.08.028","volume":"1","author":"V Bernard","year":"2017","unstructured":"Bernard V, Bishop AJ, Allen PK et al (2017) Heterogeneity in treatment response of spine metastases to spine stereotactic radiosurgery within radiosensitive subtypes. Int J Radiat Oncol Biol Phys Dec 1(5):1207\u20131215. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.08.028","journal-title":"Int J Radiat Oncol Biol Phys Dec"},{"issue":"5","key":"5033_CR47","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","volume":"1","author":"AJ Bishop","year":"2015","unstructured":"Bishop AJ, Tao R, Rebueno NC et al (2015) Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence. Int J Radiat Oncol Biol Phys Aug 1(5):1016\u20131026. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.037","journal-title":"Int J Radiat Oncol Biol Phys Aug"},{"issue":"5","key":"5033_CR48","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.ijrobp.2020.09.019","volume":"1","author":"A Sahgal","year":"2020","unstructured":"Sahgal A, Myrehaug SD, Siva S et al (2020) CCTG SC.24\/TROG 17.06: A randomized phase II\/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases. Int J Radiat Oncol Biol Phys Dec 1(5):1397\u20131398. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.09.019","journal-title":"Int J Radiat Oncol Biol Phys Dec"},{"issue":"16","key":"5033_CR49","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","volume":"16","author":"I Thibault","year":"2015","unstructured":"Thibault I, Chang EL, Sheehan J et al (2015) Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the spine response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol Dec 16(16):e595\u2013603. https:\/\/doi.org\/10.1016\/S1470-2045(15)00166-7","journal-title":"Lancet Oncol Dec"},{"issue":"3","key":"5033_CR50","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","volume":"13","author":"MH Bilsky","year":"2010","unstructured":"Bilsky MH, Laufer I, Fourney DR et al (2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine Sep 13(3):324\u2013328. https:\/\/doi.org\/10.3171\/2010.3.SPINE09459","journal-title":"J Neurosurg Spine Sep"},{"key":"5033_CR51","doi-asserted-by":"publisher","unstructured":"Fisher CG, DiPaola CP, Ryken TC et al (1976) A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine Phila Pa Oct 15 2010;35(22):E1221-9. https:\/\/doi.org\/10.1097\/BRS.0b013e3181e16ae2","DOI":"10.1097\/BRS.0b013e3181e16ae2"},{"issue":"1","key":"5033_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","volume":"16","author":"CM van Leeuwen","year":"2018","unstructured":"van Leeuwen CM, Oei AL, Crezee J et al (2018) The Alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol May 16(1):96. https:\/\/doi.org\/10.1186\/s13014-018-1040-z","journal-title":"Radiat Oncol May"},{"key":"5033_CR53","doi-asserted-by":"publisher","unstructured":"Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (1976) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine Phila Pa Jan 15 2007;32(2):193-9. https:\/\/doi.org\/10.1097\/01.brs.0000251863.76595.a2","DOI":"10.1097\/01.brs.0000251863.76595.a2"},{"issue":"3","key":"5033_CR54","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ijrobp.2018.02.035","volume":"1","author":"DC Ling","year":"2018","unstructured":"Ling DC, Flickinger JC, Burton SA et al (2018) Long-Term outcomes after stereotactic radiosurgery for spine metastases: radiation Dose-Response for late toxicity. Int J Radiat Oncol Biol Phys Jul 1(3):602\u2013609. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.035","journal-title":"Int J Radiat Oncol Biol Phys Jul"},{"key":"5033_CR55","doi-asserted-by":"publisher","unstructured":"Gerszten PC, Monaco EA 3rd, Quader M et al (2010) Setup accuracy of spine radiosurgery using cone beam computed tomography image guidance in patients with spinal implants. J Neurosurg Spine Apr 12(4):413\u2013420. https:\/\/doi.org\/10.3171\/2009.10.SPINE09249","DOI":"10.3171\/2009.10.SPINE09249"},{"key":"5033_CR56","doi-asserted-by":"publisher","unstructured":"Taori S, Adida S, Tang A et al (2024) Stereotactic radiosurgery for patients with spinal metastases from thyroid cancer: A 20-Year experience. World Neurosurg Feb 25. https:\/\/doi.org\/10.1016\/j.wneu.2024.02.102","DOI":"10.1016\/j.wneu.2024.02.102"},{"key":"5033_CR57","doi-asserted-by":"publisher","unstructured":"Taori S, Adida S, Tang A et al (2024) The role of spine stereotactic radiosurgery for patients with breast cancer metastases. J Neurooncol Feb 14. https:\/\/doi.org\/10.1007\/s11060-024-04599-1","DOI":"10.1007\/s11060-024-04599-1"},{"issue":"6","key":"5033_CR58","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1227\/neu.0000000000001909","volume":"1","author":"A Abugharib","year":"2022","unstructured":"Abugharib A, Zeng KL, Tseng CL et al (2022) Spine stereotactic body radiotherapy for prostate cancer metastases and the impact of hormone sensitivity status on local control. Neurosurg Jun 1(6):743\u2013749. https:\/\/doi.org\/10.1227\/neu.0000000000001909","journal-title":"Neurosurg Jun"},{"key":"5033_CR59","doi-asserted-by":"publisher","unstructured":"Adida S, Taori S, Bhatia S et al (2024) A case series and review of stereotactic body radiation therapy for contiguous multilevel spine metastases. J Neurooncol Nov 11. https:\/\/doi.org\/10.1007\/s11060-024-04863-4","DOI":"10.1007\/s11060-024-04863-4"},{"key":"5033_CR60","doi-asserted-by":"publisher","unstructured":"Adida S, Taori S, Donohue JK et al (2024) Stereotactic radiosurgery for patients with spinal metastases from prostate cancer. J Neurooncol Sep 24. https:\/\/doi.org\/10.1007\/s11060-024-04821-0","DOI":"10.1007\/s11060-024-04821-0"},{"key":"5033_CR61","doi-asserted-by":"publisher","unstructured":"Adida S, Kann MR, Taori S et al (2024) Safety and efficacy of Balloon-Assisted kyphoplasty followed by stereotactic body radiation therapy for pathological fractures. Neurosurg Sep 16. https:\/\/doi.org\/10.1227\/neu.0000000000003182","DOI":"10.1227\/neu.0000000000003182"},{"key":"5033_CR62","doi-asserted-by":"publisher","unstructured":"Taori S, Adida S, Kann MR et al (2024) Spine stereotactic radiosurgery provides Long-Term local control and overall survival for benign intradural tumors. Neurosurg Oct 11. https:\/\/doi.org\/10.1227\/neu.0000000000003219","DOI":"10.1227\/neu.0000000000003219"},{"key":"5033_CR63","unstructured":"U.S. Department of Health and Human Services (2017) Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. U.S. Department of Health and Human Services B, MD"},{"issue":"1","key":"5033_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE et al (2020) Global burden of 5 major types of Gastrointestinal cancer. Gastroenterol Jul 159(1):335\u2013349e15. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.068","journal-title":"Gastroenterol Jul"},{"key":"5033_CR65","doi-asserted-by":"publisher","unstructured":"Hess KR, Varadhachary GR, Taylor SH et al (2006) Metastatic patterns in adenocarcinoma. Cancer. Apr 1. ;106(7):1624-33. https:\/\/doi.org\/10.1002\/cncr.21778","DOI":"10.1002\/cncr.21778"},{"issue":"1","key":"5033_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10585-014-9686-x","volume":"32","author":"F Portales","year":"2015","unstructured":"Portales F, Thezenas S, Samalin E, Assenat E, Mazard T, Ychou M (2015) Bone metastases in Gastrointestinal cancer. Clin Exp Metastasis Jan 32(1):7\u201314. https:\/\/doi.org\/10.1007\/s10585-014-9686-x","journal-title":"Clin Exp Metastasis Jan"},{"issue":"1","key":"5033_CR67","doi-asserted-by":"publisher","first-page":"vdae051","DOI":"10.1093\/noajnl\/vdae051","volume":"6","author":"H Shakil","year":"2024","unstructured":"Shakil H, Malhotra AK, Badhiwala JH et al (2024) Contemporary trends in the incidence and timing of spinal metastases: A population-based study. Neurooncol Adv Jan-Dec 6(1):vdae051. https:\/\/doi.org\/10.1093\/noajnl\/vdae051","journal-title":"Neurooncol Adv Jan-Dec"},{"issue":"12","key":"5033_CR68","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1002\/cncr.24300","volume":"15","author":"J He","year":"2009","unstructured":"He J, Zeng ZC, Tang ZY et al (2009) Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer Jun 15(12):2710\u20132720. https:\/\/doi.org\/10.1002\/cncr.24300","journal-title":"Cancer Jun"},{"issue":"2","key":"5033_CR69","doi-asserted-by":"publisher","first-page":"225","DOI":"10.47162\/RJME.64.2.13","volume":"64","author":"S Selaru","year":"2023","unstructured":"Selaru S, Sava A, Scripcariu DV et al (2023) Epidemiological and pathological characteristics of spinal metastases from Gastrointestinal cancers - a series of 40 cases. Rom J Morphol Embryol Apr-Jun 64(2):225\u2013234. https:\/\/doi.org\/10.47162\/RJME.64.2.13","journal-title":"Rom J Morphol Embryol Apr-Jun"},{"issue":"4","key":"5033_CR70","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00520-018-4465-x","volume":"27","author":"S Dohzono","year":"2019","unstructured":"Dohzono S, Sasaoka R, Takamatsu K, Hoshino M, Nakamura H (2019) Prognostic value of paravertebral muscle density in patients with spinal metastases from Gastrointestinal cancer. Support Care Cancer Apr 27(4):1207\u20131213. https:\/\/doi.org\/10.1007\/s00520-018-4465-x","journal-title":"Support Care Cancer Apr"},{"issue":"1","key":"5033_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/jcb.30361","volume":"124","author":"JW Tessmann","year":"2023","unstructured":"Tessmann JW, Rocha MR, Morgado-Diaz JA (2023) Mechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells. J Cell Biochem Jan 124(1):31\u201345. https:\/\/doi.org\/10.1002\/jcb.30361","journal-title":"J Cell Biochem Jan"},{"issue":"1","key":"5033_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4254\/wjh.v7.i1.101","volume":"27","author":"MA Kalogeridi","year":"2015","unstructured":"Kalogeridi MA, Zygogianni A, Kyrgias G et al (2015) Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review. World J Hepatol Jan 27(1):101\u2013112. https:\/\/doi.org\/10.4254\/wjh.v7.i1.101","journal-title":"World J Hepatol Jan"},{"issue":"11","key":"5033_CR73","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/00042737-200111000-00013","volume":"13","author":"SS Chang","year":"2001","unstructured":"Chang SS, Luo JC, Chao Y et al (2001) The clinical features and prognostic factors of hepatocellular carcinoma patients with spinal metastasis. Eur J Gastroenterol Hepatol Nov 13(11):1341\u20131345. https:\/\/doi.org\/10.1097\/00042737-200111000-00013","journal-title":"Eur J Gastroenterol Hepatol Nov"},{"issue":"1","key":"5033_CR74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13014-021-01940-0","volume":"20","author":"K Makita","year":"2021","unstructured":"Makita K, Hamamoto Y, Kanzaki H et al (2021) Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study. Radiat Oncol Nov 20(1):225. https:\/\/doi.org\/10.1186\/s13014-021-01940-0","journal-title":"Radiat Oncol Nov"},{"issue":"2","key":"5033_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/a:1006312306713","volume":"44","author":"PD Brown","year":"1999","unstructured":"Brown PD, Stafford SL, Schild SE, Martenson JA, Schiff D (1999) Metastatic spinal cord compression in patients with colorectal cancer. J Neurooncol Sep 44(2):175\u2013180. https:\/\/doi.org\/10.1023\/a:1006312306713","journal-title":"J Neurooncol Sep"},{"issue":"1","key":"5033_CR76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12672-023-00651-0","volume":"22","author":"K Makita","year":"2023","unstructured":"Makita K, Hamamoto Y, Kanzaki H et al (2023) Factors affecting local control of bone metastases from radioresistant tumors treated with palliative external beam radiotherapy. Discov Oncol May 22(1):74. https:\/\/doi.org\/10.1007\/s12672-023-00651-0","journal-title":"Discov Oncol May"},{"key":"5033_CR77","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000100177","volume":"20","author":"PC Gerszten","year":"2007","unstructured":"Gerszten PC, Burton SA, Ozhasoglu C (2007) CyberKnife radiosurgery for spinal neoplasms. Prog Neurol Surg 20:340\u2013358. https:\/\/doi.org\/10.1159\/000100177","journal-title":"Prog Neurol Surg"},{"key":"5033_CR78","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.radonc.2020.01.030","volume":"146","author":"R Singh","year":"2020","unstructured":"Singh R, Lehrer EJ, Dahshan B et al (2020) Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): A systematic review and meta-analysis. Radiother Oncol May 146:76\u201389. https:\/\/doi.org\/10.1016\/j.radonc.2020.01.030","journal-title":"Radiother Oncol May"},{"issue":"2","key":"5033_CR79","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","volume":"128","author":"T Sprave","year":"2018","unstructured":"Sprave T, Verma V, Forster R et al (2018) Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother Oncol Aug 128(2):274\u2013282. https:\/\/doi.org\/10.1016\/j.radonc.2018.04.030","journal-title":"Radiother Oncol Aug"},{"issue":"2","key":"5033_CR80","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijrobp.2020.11.060","volume":"1","author":"BJ Pielkenrood","year":"2021","unstructured":"Pielkenrood BJ, van der Velden JM, van der Linden YM et al (2021) Pain response after stereotactic body radiation therapy versus conventional radiation therapy in patients with bone Metastases-A phase 2 randomized controlled trial within a prospective cohort. Int J Radiat Oncol Biol Phys Jun 1(2):358\u2013367. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.060","journal-title":"Int J Radiat Oncol Biol Phys Jun"},{"key":"5033_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fonc.2019.00337","volume":"9","author":"KL Zeng","year":"2019","unstructured":"Zeng KL, Tseng CL, Soliman H, Weiss Y, Sahgal A, Myrehaug S (2019) Stereotactic body radiotherapy (SBRT) for oligometastatic spine metastases: an overview. Front Oncol 9:337. https:\/\/doi.org\/10.3389\/fonc.2019.00337","journal-title":"Front Oncol"},{"issue":"2","key":"5033_CR82","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","volume":"33","author":"M Guckenberger","year":"2023","unstructured":"Guckenberger M, Dahele M, Ong WL, Sahgal A (2023) Stereotactic body radiation therapy for spinal metastases: benefits and limitations. Semin Radiat Oncol Apr 33(2):159\u2013171. https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.006","journal-title":"Semin Radiat Oncol Apr"},{"key":"5033_CR83","doi-asserted-by":"publisher","first-page":"100845","DOI":"10.1016\/j.ctro.2024.100845","volume":"49","author":"M Bilski","year":"2024","unstructured":"Bilski M, Konat-Baska K, Mastroleo F et al (2024) Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era - A systematic review. Clin Transl Radiat Oncol Nov 49:100845. https:\/\/doi.org\/10.1016\/j.ctro.2024.100845","journal-title":"Clin Transl Radiat Oncol Nov"},{"key":"5033_CR84","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.wneu.2022.10.053","volume":"169","author":"VB Chakravarthy","year":"2023","unstructured":"Chakravarthy VB, Schachner B, Amin A et al (2023) Long-Term clinical outcomes of patients with colorectal cancer with metastatic epidural spinal cord compression treated with hybrid therapy (Surgery followed by stereotactic body radiation therapy). World Neurosurg Jan 169:e89\u2013e95. https:\/\/doi.org\/10.1016\/j.wneu.2022.10.053","journal-title":"World Neurosurg Jan"},{"issue":"3","key":"5033_CR85","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/s0167-8140(02)00170-6","volume":"64","author":"E Chow","year":"2002","unstructured":"Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol Sep 64(3):275\u2013280. https:\/\/doi.org\/10.1016\/s0167-8140(02)00170-6","journal-title":"Radiother Oncol Sep"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05033-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05033-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T10:48:33Z","timestamp":1750070913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05033-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5033"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05033-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The University of Pittsburgh Institutional Review Board has confirmed ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}